Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Tralokinumab
Tralokinumab
+1 more
Locations
45
United States
Research Site
Phoenix, Arizona, United States
Research Site
La Jolla, California, United States
Research Site
Sacramento, California, United States
Research Site
Tampa, Florida, United States
Research Site
Winter Park, Florida, United States
Research Site
Atlanta, Georgia, United States
Start Date
October 1, 2012
Primary Completion Date
May 1, 2015
Completion Date
January 1, 2016
Last Updated
May 15, 2017
NCT06238622
NCT07299695
NCT07466420
NCT06241560
NCT05674994
NCT07407543
Lead Sponsor
MedImmune LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions